488 related articles for article (PubMed ID: 28264694)
1. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.
Fonseca MI; Chu SH; Hernandez MX; Fang MJ; Modarresi L; Selvan P; MacGregor GR; Tenner AJ
J Neuroinflammation; 2017 Mar; 14(1):48. PubMed ID: 28264694
[TBL] [Abstract][Full Text] [Related]
2. Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration.
Jiao H; Rutar M; Fernando N; Yednock T; Sankaranarayanan S; Aggio-Bruce R; Provis J; Natoli R
Mol Neurodegener; 2018 Aug; 13(1):45. PubMed ID: 30126455
[TBL] [Abstract][Full Text] [Related]
3. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.
Liu Z; Condello C; Schain A; Harb R; Grutzendler J
J Neurosci; 2010 Dec; 30(50):17091-101. PubMed ID: 21159979
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis.
Doroshenko ER; Drohomyrecky PC; Gower A; Whetstone H; Cahill LS; Ganguly M; Spring S; Yi TJ; Sled JG; Dunn SE
Front Immunol; 2021; 12():570425. PubMed ID: 33732230
[TBL] [Abstract][Full Text] [Related]
5. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
[TBL] [Abstract][Full Text] [Related]
6. HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q.
Hammond JW; Qiu WQ; Marker DF; Chamberlain JM; Greaves-Tunnell W; Bellizzi MJ; Lu SM; Gelbard HA
Glia; 2018 Dec; 66(12):2563-2574. PubMed ID: 30325063
[TBL] [Abstract][Full Text] [Related]
7. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice.
Fumagalli S; Perego C; Ortolano F; De Simoni MG
Glia; 2013 Jun; 61(6):827-42. PubMed ID: 23440897
[TBL] [Abstract][Full Text] [Related]
8. Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling.
Liang KJ; Lee JE; Wang YD; Ma W; Fontainhas AM; Fariss RN; Wong WT
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4444-51. PubMed ID: 19443728
[TBL] [Abstract][Full Text] [Related]
9. Complement is dispensable for neurodegeneration in Niemann-Pick disease type C.
Lopez ME; Klein AD; Scott MP
J Neuroinflammation; 2012 Sep; 9():216. PubMed ID: 22985423
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells.
Petry F; Botto M; Holtappels R; Walport MJ; Loos M
J Immunol; 2001 Oct; 167(7):4033-7. PubMed ID: 11564823
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Socs3 in LysM
Du X; Penalva R; Little K; Kissenpfennig A; Chen M; Xu H
Mol Neurodegener; 2021 Feb; 16(1):9. PubMed ID: 33602265
[TBL] [Abstract][Full Text] [Related]
12. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
13. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.
Cohen JI; Roychowdhury S; McMullen MR; Stavitsky AB; Nagy LE
Gastroenterology; 2010 Aug; 139(2):664-74, 674.e1. PubMed ID: 20416309
[TBL] [Abstract][Full Text] [Related]
14. Injury Leads to the Appearance of Cells with Characteristics of Both Microglia and Astrocytes in Mouse and Human Brain.
Wilhelmsson U; Andersson D; de Pablo Y; Pekny R; Ståhlberg A; Mulder J; Mitsios N; Hortobágyi T; Pekny M; Pekna M
Cereb Cortex; 2017 Jun; 27(6):3360-3377. PubMed ID: 28398520
[TBL] [Abstract][Full Text] [Related]
15. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.
Fuhrmann M; Bittner T; Jung CK; Burgold S; Page RM; Mitteregger G; Haass C; LaFerla FM; Kretzschmar H; Herms J
Nat Neurosci; 2010 Apr; 13(4):411-3. PubMed ID: 20305648
[TBL] [Abstract][Full Text] [Related]
16. Cx3cr1
Lee Y; Lee JW; Nam H; Yu SW
Mol Brain; 2020 Jun; 13(1):88. PubMed ID: 32513210
[TBL] [Abstract][Full Text] [Related]
17. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge.
Wynne AM; Henry CJ; Huang Y; Cleland A; Godbout JP
Brain Behav Immun; 2010 Oct; 24(7):1190-201. PubMed ID: 20570721
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
Front Immunol; 2019; 10():2780. PubMed ID: 31849963
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA/2NNia Mice.
Kumari R; Astafurov K; Genis A; Danias J
PLoS One; 2015; 10(11):e0142199. PubMed ID: 26544197
[TBL] [Abstract][Full Text] [Related]
20. Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia.
Linnartz B; Kopatz J; Tenner AJ; Neumann H
J Neurosci; 2012 Jan; 32(3):946-52. PubMed ID: 22262892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
